Abstract
Natural killer (NK) cells were shown to secrete differentially interleukins (IL), IL-1 alpha, IL-1 beta, IL-2, IL-8, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha), granulocyte-macrophage colony-stimulating factor (GM-CSF), and leukaemia inhibitory factor (LIF) upon stimulation with optimal concentrations of chylomicrons (CM), very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL), high-density lipoprotein (HDL) or acetyl-modified low-density lipoprotein (AcLDL). CM, VLDL, LDL and AcLDL induced LIF secretion which was absent in nonstimulated cells. CM, VLDL, and LDL did not affect IL-1 alpha secretion. CM stimulated IL-8 > TNF-alpha > IL-1 alpha > IL-2 = IFN-gamma, and decreased seventeen-fold GM-CSF secretion. VLDL stimulated IL-8 secretion > IL-1 alpha = IL-2 > IFN-gamma > TNF-alpha and decreased fivefold GM-CSF secretion. LDL stimulated IL-8 secretion > IL-1 alpha > IL-2 = IFN-gamma, it did not modify TNF-alpha and inhibited five hundred-fold GM-CSF secretion. HDL stimulated IL-2 secretion = IFN-gamma > IL-8, it decreased GM-CSF secretion > IL-1 alpha > IL-1 beta > TNF-alpha without affecting LIF. AcLDL stimulated IL-8 secretion > TNF-alpha > IL-1 alpha > IL-2 = IFN-gamma = IL-1 beta, and ...Continue Reading
References
Sep 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·S K BasuM S Brown
Jun 1, 1992·Current Opinion in Immunology·K A Smith
Apr 1, 1992·The Journal of Clinical Investigation·Y J Geng, G K Hansson
Nov 1, 1990·Immunology Today·K N TraillG Jürgens
Aug 22, 1989·Biochimica Et Biophysica Acta·R AlamS Alam
Jan 1, 1994·Annual Review of Biochemistry·M Krieger, J Herz
Jul 1, 1994·Endocrinology·M K MarshallC Grunfeld
Aug 1, 1994·Scandinavian Journal of Immunology·B Naume, T Espevik
Apr 29, 1993·Nature·R Ross
Jan 10, 1996·Cellular Immunology·J B De SanctisN E Bianco
Dec 1, 1995·Journal of Internal Medicine·T Yokota, G K Hansson
Citations
Aug 15, 2002·Transplantation Proceedings·H J GasselC Otto
Dec 29, 1998·Transplantation Proceedings·M G von Herrath
Jul 20, 2002·The Journal of Steroid Biochemistry and Molecular Biology·Lev E PaninIrina M Korostyshevskaya
Aug 7, 1998·European Journal of Clinical Investigation·S D Proctor, J C Mamo
Jun 17, 2003·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Tomiya YasumasuYasuhide Nakashima
Oct 11, 2012·PloS One·Hao Hong YiuRobert F Stengel
Oct 13, 2015·Journal of Medicinal Chemistry·Mashooq A BhatSheikh F Ahmad
Sep 16, 2015·Cytokine·Anupam DuttaShashi Baruah
Jul 26, 2006·British Journal of Pharmacology·Susana E MorenoBernardo Boris Vargaftig
Jun 25, 2010·Journal of Periodontal Research·T KikuchiJ G Tew
Oct 17, 2002·Cellular Immunology·Jennifer L BiberWilliam Carson
Mar 6, 2012·Atherosclerosis·Nan HouChunhong Ma
Sep 16, 2014·PloS One·Naresh C LaddhaRasheedunnisa Begum
Aug 27, 2016·PloS One·Fei ChengMichael Torzewski
Jul 14, 2016·The Journal of General Virology·Narmadha SubramanianThomas M Mertens
Sep 7, 2016·Archives of Toxicology·Tamara J Martin, Margaret M Whalen
May 5, 2017·British Journal of Pharmacology·Tin KyawAlex Bobik
Sep 22, 2017·Oncoimmunology·Maulik VyasElke Pogge von Strandmann
Mar 4, 2000·The Journal of Biological Chemistry·E M FallonD A Lauffenburger
Feb 6, 2017·Frontiers in Immunology·Gerald MoncayoChristopher A O'Callaghan
Sep 12, 2017·Immunological Investigations·Munendra Singh TomarArbind Acharya
Jun 24, 2003·AIDS·Carlos Alonso-VillaverdeLluis Masana
Oct 28, 2005·The Journal of Biological Chemistry·Iveta DobrevaChristian Widmann
Sep 24, 2020·Chembiochem : a European Journal of Chemical Biology·Dante Descalzi-MontoyaDavid Sabatino
Sep 12, 2020·Current Drug Targets·Adekunle Babajide RowaiyeCharles Okechukwu Esimone